Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
100%(2 trials)
Terminated
1(25%)

Phase Distribution

Ph phase_4
1
25%
Ph not_applicable
1
25%
Ph phase_2
2
50%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Terminated(1)
Other(1)

Detailed Status

Completed2
Terminated1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)

Trials by Status

terminated125%
unknown125%
completed250%

Recent Activity

0 active trials
Showing 4 of 4
terminatedphase_2

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

NCT04152161
unknownphase_4

Influence of BCG on TDaP-IPV Vaccination

NCT02771782
completednot_applicable

γ-irradiated BCG to Train Innate Immunity

NCT02259608
completedphase_2

Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination

NCT01650389

Clinical Trials (4)

Showing 4 of 4 trials
NCT04152161Phase 2

Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection

Terminated
NCT02771782Phase 4

Influence of BCG on TDaP-IPV Vaccination

Unknown
NCT02259608Not Applicable

γ-irradiated BCG to Train Innate Immunity

Completed
NCT01650389Phase 2

Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination

Completed

All 4 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
4